UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Evaluation of the lung cancer risks at which to screen ever- and never-smokers: screening rules applied to the PLCO and NLST cohorts

PLoS medicine, 2014-12, Vol.11 (12), p.e1001764-e1001764

2014

Volltextzugriff (PDF)

Implications of Nine Risk Prediction Models for Selecting Ever-Smokers for Computed Tomography Lung Cancer Screening

Annals of internal medicine, 2018-07, Vol.169 (1), p.10

2018

Volltextzugriff (PDF)

Proportion of second cancers attributable to radiotherapy treatment in adults: a cohort study in the US SEER cancer registries

The lancet oncology, 2011-04, Vol.12 (4), p.353-360

2011

Volltextzugriff (PDF)

Targeting of Low-Dose CT Screening According to the Risk of Lung-Cancer Death

The New England journal of medicine, 2013-07, Vol.369 (3), p.245-254

2013

Volltextzugriff (PDF)

Impact of Lung Cancer Screening Results on Smoking Cessation

JNCI : Journal of the National Cancer Institute, 2014-06, Vol.106 (6), p.dju084

2014

Volltextzugriff (PDF)

Results of the Two Incidence Screenings in the National Lung Screening Trial

The New England journal of medicine, 2013-09, Vol.369 (10), p.920-931

2013

Volltextzugriff (PDF)

The Decrease in Breast-Cancer Incidence in 2003 in the United States

The New England journal of medicine, 2007-04, Vol.356 (16), p.1670-1674

2007

Volltextzugriff (PDF)

Lung Cancer Risk Prediction: Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Models and Validation

JNCI : Journal of the National Cancer Institute, 2011-07, Vol.103 (13), p.1058-1068

2011

Volltextzugriff (PDF)

Estrogen Metabolism and Risk of Breast Cancer in Postmenopausal Women

JNCI : Journal of the National Cancer Institute, 2012-02, Vol.104 (4), p.326-339

2012

Volltextzugriff (PDF)

Addressing oncology's contribution to climate change

The lancet oncology, 2024-06, Vol.25 (6), p.690-691

Berg, Christine D

2024

Volltextzugriff (PDF)

Outcomes from ovarian cancer screening in the PLCO trial: Histologic heterogeneity impacts detection, overdiagnosis and survival

European journal of cancer (1990), 2017-12, Vol.87, p.182-188

2017

Volltextzugriff (PDF)

Comorbidity and Mortality Results From a Randomized Prostate Cancer Screening Trial

Journal of clinical oncology, 2011-02, Vol.29 (4), p.355-361

2011

Volltextzugriff (PDF)

Ovarian cancer biomarker performance in prostate, lung, colorectal, and ovarian cancer screening trial specimens

Cancer prevention research (Philadelphia, Pa.), 2011-03, Vol.4 (3), p.365-374

2011

Volltextzugriff (PDF)

Longitudinal Screening Algorithm That Incorporates Change Over Time in CA125 Levels Identifies Ovarian Cancer Earlier Than a Single-Threshold Rule

Journal of clinical oncology, 2013-01, Vol.31 (3), p.387-392

2013

Volltextzugriff (PDF)

Cancer Prevention and Screening: Concepts, Principles and Controversies

1st, 2018

Volltextzugriff (PDF)

Modeled Reductions in Late-stage Cancer with a Multi-Cancer Early Detection Test

Cancer epidemiology, biomarkers & prevention, 2021-03, Vol.30 (3), p.460-468

2021

Volltextzugriff (PDF)

Radiation-related cancer risks from CT colonography screening: a risk-benefit analysis

American journal of roentgenology (1976), 2011-04, Vol.196 (4), p.816-823

2011

Volltextzugriff (PDF)

Serum Levels of Vitamin D Metabolites and Breast Cancer Risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial

Cancer epidemiology, biomarkers & prevention, 2008-04, Vol.17 (4), p.889-894

2008

Volltextzugriff (PDF)

Improving selection of individuals into lung cancer screening programmes

The lancet oncology, 2019-08, Vol.20 (8), p.1039-1040

Berg, Christine D

2019

Volltextzugriff (PDF)

Data sharing in clinical trials: An experience with two large cancer screening trials

PLoS medicine, 2017-05, Vol.14 (5), p.e1002304-e1002304

2017

Volltextzugriff (PDF)

An efficient randomised trial design for multi-cancer screening blood tests: nested enhanced mortality outcomes of screening trial

The lancet oncology, 2021-10, Vol.22 (10), p.1360-1362

2021

Volltextzugriff (PDF)

Development and Validation of Risk Models to Select Ever-Smokers for CT Lung Cancer Screening

JAMA : the journal of the American Medical Association, 2016-06, Vol.315 (21), p.2300

2016

Volltextzugriff (PDF)

Breast cancer epidemiology according to recognized breast cancer risk factors in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial Cohort

BMC cancer, 2009-03, Vol.9 (1), p.84-84, Article 84

2009

Volltextzugriff (PDF)

Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening

The New England journal of medicine, 2011-08, Vol.365 (5), p.395-409

2011

Volltextzugriff (PDF)

Lung Cancer Screening in the Randomized Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial

JNCI : Journal of the National Cancer Institute, 2010-05, Vol.102 (10), p.722-731

2010

Volltextzugriff (PDF)

1 – 25 von 484

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(417)
Mit Volltextzugriff
(394)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Evaluation of the lung cancer risks at which to screen ever- and never-smokers: screening rules applied to the PLCO and NLST cohorts

Implications of Nine Risk Prediction Models for Selecting Ever-Smokers for Computed Tomography Lung Cancer Screening

Proportion of second cancers attributable to radiotherapy treatment in adults: a cohort study in the US SEER cancer registries

Targeting of Low-Dose CT Screening According to the Risk of Lung-Cancer Death

Impact of Lung Cancer Screening Results on Smoking Cessation

Results of the Two Incidence Screenings in the National Lung Screening Trial

The Decrease in Breast-Cancer Incidence in 2003 in the United States

Lung Cancer Risk Prediction: Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Models and Validation

Estrogen Metabolism and Risk of Breast Cancer in Postmenopausal Women

Addressing oncology's contribution to climate change

Outcomes from ovarian cancer screening in the PLCO trial: Histologic heterogeneity impacts detection, overdiagnosis and survival

Comorbidity and Mortality Results From a Randomized Prostate Cancer Screening Trial

Ovarian cancer biomarker performance in prostate, lung, colorectal, and ovarian cancer screening trial specimens

Longitudinal Screening Algorithm That Incorporates Change Over Time in CA125 Levels Identifies Ovarian Cancer Earlier Than a Single-Threshold Rule

Cancer Prevention and Screening: Concepts, Principles and Controversies

Modeled Reductions in Late-stage Cancer with a Multi-Cancer Early Detection Test

Radiation-related cancer risks from CT colonography screening: a risk-benefit analysis

Serum Levels of Vitamin D Metabolites and Breast Cancer Risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial

Improving selection of individuals into lung cancer screening programmes

Data sharing in clinical trials: An experience with two large cancer screening trials

An efficient randomised trial design for multi-cancer screening blood tests: nested enhanced mortality outcomes of screening trial

Development and Validation of Risk Models to Select Ever-Smokers for CT Lung Cancer Screening

Breast cancer epidemiology according to recognized breast cancer risk factors in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial Cohort

Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening

Lung Cancer Screening in the Randomized Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial

Suchergebnisse filtern